MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
KVUE stock logo

KVUE

Kenvue Inc.

$17.14
-0.24
 (-1.38%)
Exchange:  NYSE
Market Cap:  32.853B
Shares Outstanding:  1.889B
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Consumer Defensive
Industry:  Household & Personal Products
   
CEO:  Kirk L. Perry
Full Time Employees:  22000
Address: 
1 Kenvue Way
Summit
NJ
7901
US
Website:  https://www.kenvue.com
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women’s health, and wound care products under the Listerine, Johnson’s, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/05/08 — Q1 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue15,444,00015,455,00015,124,000
Gross Profit8,643,0008,959,0008,792,000
EBITDA3,175,0002,468,0002,935,000
Operating Income2,512,0001,841,0002,704,000
Net Income1,664,0001,030,0001,470,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets27,851,00025,601,00027,076,000
Total Liabilities16,640,00015,933,00016,311,000
Total Stockholders Equity11,211,0009,668,00010,765,000
Total Debt8,427,0008,719,0008,524,000
Cash and Cash Equivalents1,382,0001,070,0001,062,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow3,168,0001,769,0002,200
Capital Expenditure-469,000-434,000-500
Free Cash Flow2,699,0001,335,0001,700
Net Income1,664,0001,030,0001,470,000
Net Change in Cash151,000-312,0000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)17,042,067.271Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)17,318,954.886Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)17,172,722.994Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)3,482,230.205Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)3,538,807.051Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)3,508,927.278Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)2,462,777.721Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)2,514,918.121Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)2,487,385.681Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)6,582,389.075Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)6,689,335.138Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)6,632,854.009Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)1.290Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)1.310Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)1.280Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)4Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
15.456B  ?P/S
 (TTM)
: 
2.23
?Net Income
 (TTM)
: 
1.03B  ?P/E
 (TTM)
: 
22.95
?Enterprise Value
 (TTM)
: 
41.216B  ?EV/FCF
 (TTM)
: 
23.93
?Dividend Yield
 (TTM)
: 
0.05  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
0.14  ?ROIC
 (TTM)
: 
0.09
?Net Debt
 (TTM)
: 
7.649B  ?Debt/Equity
 (TTM)
: 
0.79
?P/B
 (TTM)
: 
3.13  ?Current Ratio
 (TTM)
: 
0.96

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
15.04Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates KVUE intrinsic value between $10.22 – $19.19 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate KVUE Intrinsic Value

Common questions about KVUE valuation

Is Kenvue Inc. (KVUE) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Kenvue Inc. (KVUE) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is KVUE a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether KVUE trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is KVUE’s P/E ratio?

You can see KVUE’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for KVUE?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is KVUE a good long-term investment?

Whether KVUE fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

KVUE

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-1.38
MARKETSnap

Trading Metrics:

Open: 17.36   Previous Close: 17.38
Day Low: 17.12   Day High: 17.44
Year Low: 14.02   Year High: 25.17
Price Avg 50: 17.98   Price Avg 200: 18.32
Volume: 13.128M   Average Volume: 33.889M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Kenvue to Announce First Quarter 2026 Results on May 7, 2026
23-04-2026 16:32
Kenvue to Announce First Quarter 2026 Results on May 7, 2026
Kimberly-Clark: This 5% Yielder Is A Buy Ahead Of The Kenvue Merger
20-04-2026 17:33
Kimberly-Clark: This 5% Yielder Is A Buy Ahead Of The Kenvue Merger
Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal
15-04-2026 09:52
Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal
Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership
15-04-2026 08:55
Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership
Alpha Omega Wealth Management LLC Sells 167,069 Shares of Kenvue Inc. $KVUE
10-04-2026 03:20
Alpha Omega Wealth Management LLC Sells 167,069 Shares of Kenvue Inc. $KVUE
Kenvue (NYSE:KVUE) vs. Synergy CHC (NASDAQ:SNYR) Head-To-Head Comparison
01-04-2026 01:10
Kenvue (NYSE:KVUE) vs. Synergy CHC (NASDAQ:SNYR) Head-To-Head Comparison

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read